New Publication in Vaccine Highlights Preclinical Results of Vaxart's Mucosal Chikungunya Vaccine - Argus Press

New Publication in Vaccine Highlights Preclinical Results of Vaxart's Mucosal Chikungunya Vaccine  Argus Press

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--May 29, 2019--. Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral ...



Comments

Popular posts from this blog

8 Ways to Get Care When There Are No Primary Care Doctors - U.S. News & World Report

Vaccines Offer Protection Against Cold and Cough Symptoms - Pharmacy Times